PrimeCell Overview
- Year Founded
-
2007

- Status
-
Private
- Employees
-
100

- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
2
- Investments
-
1
PrimeCell General Information
Description
Developer of regenerative medicine focused on discovering and clinical testing of biological drugs and medicinal technologies. The company's scientific and manufacturing infrastructure utilizes technologies to develop, process and manufacture human cell and tissue products that change genes and cells parameters to support the regeneration of human tissues and organs, thereby enabling physicians and patients with new treatments that use human cells and new materials such as nanomaterials to treat serious diseases.
Contact Information
Website
www.primecell.euCorporate Office
- BioIncubator 4MEDi, University Hospital
- Dr. Slabihoudka 11
- Ostrava, 708 00
- Czech Republic
Corporate Office
- BioIncubator 4MEDi, University Hospital
- Dr. Slabihoudka 11
- Ostrava, 708 00
- Czech Republic
PrimeCell Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
PrimeCell Patents
PrimeCell Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3851853-A1 | Method for separation of sperm with undamaged intact heads from sperm with damaged heads and somatic cells | Inactive | 17-Jan-2020 | ||
US-20230044560-A1 | Method for separation of sperm with undamaged intact heads from sperm with damaged heads and somatic cells | Pending | 17-Jan-2020 | ||
EP-3851852-A1 | Method for separation of sperm with undamaged intact heads from sperm with damaged heads and somatic cells | Inactive | 17-Jan-2020 | ||
EP-4090972-A1 | Method for separation of sperm with undamaged intact heads from sperm with damaged heads and somatic cells | Inactive | 17-Jan-2020 | ||
US-20190234933-A1 | Compositions and assays | Inactive | 01-Feb-2018 | C12Q1/025 |
PrimeCell Signals
PrimeCell Investments (1)
PrimeCell’s most recent deal was a Buyout/LBO with Rodinná Banka Perinatálních a Mesenchymálních Buněk for . The deal was made on 21-Dec-2020.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Rodinná Banka Perinatálních a Mesenchymálních Buněk | 21-Dec-2020 | Buyout/LBO | Other Healthcare Services |
PrimeCell Affiliates
Subsidiaries (1)
Name | Industry | Location | Year Founded |
---|---|---|---|
Rodinná Banka Perinatálních a Mesenchymálních Buněk | Ostrava, Czech Republic | 2009 |
PrimeCell FAQs
-
When was PrimeCell founded?
PrimeCell was founded in 2007.
-
Where is PrimeCell headquartered?
PrimeCell is headquartered in Ostrava, Czech Republic.
-
What is the size of PrimeCell?
PrimeCell has 100 total employees.
-
What industry is PrimeCell in?
PrimeCell’s primary industry is Pharmaceuticals.
-
Is PrimeCell a private or public company?
PrimeCell is a Private company.
-
What is PrimeCell’s current revenue?
The current revenue for PrimeCell is
.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »